Roles for Taraxacum officinale and Vitamins (C, K) on Bone Formation and Resorption Heparin-Induced in Rats

[1]  E. A. Eid,et al.  Impact of Dehydroepiandrosterone (DHEA) on Bone Mineral Density and Bone Mineral Content in a Rat Model of Male Hypogonadism , 2020, Veterinary sciences.

[2]  A. Poupon,et al.  Characterization of New Monoclonal PF4-Specific Antibodies as Useful Tools for Studies on Typical and Autoimmune Heparin-Induced Thrombocytopenia , 2020, Thrombosis and Haemostasis.

[3]  J. Makowska,et al.  Role of Vitamin C in Osteoporosis Development and Treatment—A Literature Review , 2020, Nutrients.

[4]  X. Zhang,et al.  Effect of long‐term use of unfractionated or low‐molecular‐weight heparin on bone mineral density in maintenance hemodialysis patients , 2020, Hemodialysis international. International Symposium on Home Hemodialysis.

[5]  M. da Cunha,et al.  Vitamin K Supplementation Modulates Bone Metabolism and Ultra-Structure of Ovariectomized Mice , 2018, Cellular Physiology and Biochemistry.

[6]  S. Akbari,et al.  Vitamin K and Bone Metabolism: A Review of the Latest Evidence in Preclinical Studies , 2018, BioMed research international.

[7]  H. Martino,et al.  Effect of vitamin K in bone metabolism and vascular calcification: A review of mechanisms of action and evidences , 2017, Critical reviews in food science and nutrition.

[8]  M. Leblanc,et al.  Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis , 2017, BMC Nephrology.

[9]  Chih-Hwa Chen,et al.  Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives , 2017, Biomarker Research.

[10]  N. Napoli,et al.  Vitamin K and osteoporosis: Myth or reality? , 2017, Metabolism: clinical and experimental.

[11]  M. Fusaro,et al.  Vitamin K and bone. , 2017, Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases.

[12]  R. Linhardt,et al.  Heparin: Past, Present, and Future , 2016, Pharmaceuticals.

[13]  D. Lu,et al.  Unfractionated Heparin Promotes Osteoclast Formation in Vitro by Inhibiting Osteoprotegerin Activity , 2016, International journal of molecular sciences.

[14]  H. Ho,et al.  In vitro vitamin K(2) and 1α,25-dihydroxyvitamin D(3) combination enhances osteoblasts anabolism of diabetic mice. , 2015, European journal of pharmacology.

[15]  Subburaman Mohan,et al.  The Roles and Mechanisms of Actions of Vitamin C in Bone: New Developments , 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  F. Jakob,et al.  Heparin affects human bone marrow stromal cell fate: Promoting osteogenic and reducing adipogenic differentiation and conversion. , 2015, Bone.

[17]  Jia-ning Zu,et al.  Comparison of the effects of heparin and the direct factor Xa inhibitor, rivaroxaban, on bone microstructure and metabolism in adult rats , 2015, Connective tissue research.

[18]  B. Fang,et al.  Ovariectomy induces osteoporosis in the maxillary alveolar bone: an in vivo micro-CT and histomorphometric analysis in rats. , 2014, Oral diseases.

[19]  Misung Kim,et al.  Vitamin K1 (phylloquinone) and K2 (menaquinone-4) supplementation improves bone formation in a high-fat diet-induced obese mice , 2013, Journal of clinical biochemistry and nutrition.

[20]  I. M. Dagsuyu,et al.  Therapeutic effects of alpha lipoic acid and vitamin C on alveolar bone resorption after experimental periodontitis in rats: a biochemical, histochemical, and stereologic study. , 2013, Journal of periodontology.

[21]  K. Rahman,et al.  Effects and Interaction of Icariin, Curculigoside, and Berberine in Er-Xian Decoction, a Traditional Chinese Medicinal Formula, on Osteoclastic Bone Resorption , 2012, Evidence-based complementary and alternative medicine : eCAM.

[22]  K. Jeong,et al.  Vitamin C deficiency accelerates bone loss inducing an increase in PPAR‐γ expression in SMP30 knockout mice , 2012, International journal of experimental pathology.

[23]  F. Visioli,et al.  Diverse biological activities of dandelion. , 2012, Nutrition reviews.

[24]  Jinhu Xiong,et al.  Matrix-embedded cells control osteoclast formation , 2011, Nature Medicine.

[25]  L. Xing,et al.  Functions of RANKL/RANK/OPG in bone modeling and remodeling. , 2008, Archives of biochemistry and biophysics.

[26]  M. McKee,et al.  Endocrine Regulation of Energy Metabolism by the Skeleton , 2007, Cell.

[27]  W. Kuis,et al.  Pronounced Elevation of Undercarboxylated Osteocalcin in Healthy Children , 2007, Pediatric Research.

[28]  C. Palacios.  The Role of Nutrients in Bone Health, from A to Z , 2006, Critical reviews in food science and nutrition.

[29]  S. Abrams,et al.  A combination of prebiotic short- and long-chain inulin-type fructans enhances calcium absorption and bone mineralization in young adolescents , 2005 .

[30]  E. Frenkel,et al.  Unfractionated heparin, low molecular weight heparins, and pentasaccharide: basic mechanism of actions, pharmacology, and clinical use. , 2005, Hematology/oncology clinics of North America.

[31]  Kwan Tat Steeve,et al.  IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. , 2004 .

[32]  A. Torbicki,et al.  Changes in Bone Density during Long-Term Administration of Low-Molecular-Weight Heparins or Acenocoumarol for Secondary Prophylaxis of Venous Thromboembolism , 2003, Pathophysiology of Haemostasis and Thrombosis.

[33]  K. Hara,et al.  Inhibitory effect of vitamin K2 (menatetrenone) on bone resorption in ovariectomized rats: a histomorphometric and dual energy X-ray absorptiometric study. , 1999, Japanese journal of pharmacology.

[34]  R. Franceschi,et al.  Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3‐E1 cells , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  J. Crockett,et al.  New knowledge on critical osteoclast formation and activation pathways from study of rare genetic diseases of osteoclasts: focus on the RANK/RANKL axis , 2010, Osteoporosis International.

[36]  Patricia A Downey,et al.  Bone biology and the clinical implications for osteoporosis. , 2006, Physical therapy.